Sevasti Margetas, DO
General Practice · Allentown, PANPI 1659533289
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $590, 2.8 times the $209 reported in 2019. Among general practice clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$444
- E.r. Squibb & Sons, L.L.C.$255
- Johnson & Johnson$252
- Incyte Corporation$245
- Sun Pharmaceutical Industries Inc.$243
- Pfizer$194
- plus $857 from 15 others
What the payments were for
- Food & beverage$2,37895%
- Education$1135%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $444 |
| E.r. Squibb & Sons, L.L.C. | 18 | $255 |
| Johnson & Johnson | 14 | $252 |
| Incyte Corporation | 9 | $245 |
| Sun Pharmaceutical Industries Inc. | 8 | $243 |
| Pfizer | 13 | $194 |
| Amgen | 7 | $141 |
| Novartis | 6 | $109 |
| Lilly USA, LLC | 6 | $105 |
| UCB, Inc. | 5 | $94 |
| Galderma Laboratories, L.p. | 6 | $85 |
| Helsinn Therapeutics (U.S.), Inc. | 5 | $71 |
| Sanofi | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 4 | $62 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Journey Medical Corporation | 1 | $21 |
| Biocon Biologics Inc | 1 | $20 |
| Bristol Myers Squibb | 1 | $18 |
| Dermavant Sciences, Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $13 |
| Organon | 1 | $7 |
How this compares
$2,491 in reported general payments places this provider in the 95th percentile of 3,208 general practice providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 55 | $3,426 |
| Metronidazole | 34 | $1,820 |
| Ketoconazole | 72 | $1,149 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 13 | $466 |
| Mupirocin | 36 | $267 |
| Clindamycin Phosphate | 11 | $239 |
| Spironolactone | 12 | $235 |
| Triamcinolone Acetonide | 24 | $187 |
| Hydrocortisone | 18 | $61 |
Paid to pharmacies, not to this prescriber.
Other general practice in Allentown
- Corey AnolikPhiladelphia$2.1M
- Richard NagelbergPlymouth Meeting$1.4M
- Alan AtlasPhiladelphia$486K
- Susan McMahonPittsburgh$364K
- Carl MedgausMonroeville$192K
- Yooson KimMorgantown$166K
- Michael WollockArdmore$113K
- Marc ManosPhiladelphia$85K
- Michele ColumboBryn Mawr$79K
- Robert MarusYardley$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.